Delivery Order SPE2DB22D2007-SPE2DB25FJ4XM
- Not listed
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of September 25, 2025. This competitive delivery order represents a firm fixed price transaction with no set-aside designation. The award was made on September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,007.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,007.12 for Zymfentra 120 mg/ml pens (2-pack quantity) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location. This delivery order...
- The Defense Logistics Agency awarded a $1,503.56 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,007.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 2, 2025. This non-competitive delivery order was issued on August 11, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $4,212.90 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack units) on September 8, 2025, with an ultimate completion date of September 29, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen (2-pack units) on August 5, 2025, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a $3,007.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) pharmaceutical supplies. The award, announced on May 13, 2025, with an ultimate completion date of June 4, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations as a major...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4XMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits valued at $1,503.56, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Zymfentra, a GLP-1 receptor agonist used for diabetes and weight management, reflects the company's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through flexible, comprehensive contract vehicles designed to meet global military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/12/25 |